Association of adenovirus 36 infection with adiposity and inflammatory-related markers in children

J Clin Endocrinol Metab. 2014 Sep;99(9):3240-6. doi: 10.1210/jc.2014-1780. Epub 2014 Jun 13.

Abstract

Context: Although animal studies suggest that adenovirus 36 (Ad36) infection is linked to obesity and systemic inflammation, human data are scant and equivocal.

Objective: Associations of Ad36 infection with total body adiposity and inflammatory-related markers were determined in 291 children aged 9-13 years (50% female, 49% black).

Design: Fasting blood samples were measured for presence of Ad36-specific antibodies and TNF-α, IL-6, vascular endothelial growth factor (VEGF), and monocyte chemoattractant protein-1 (MCP-1). Fat mass and fat-free soft tissue mass were measured by dual-energy X-ray absorptiometry.

Results: The overall prevalence of Ad36 seropositivity [Ad36(+)] was 42%. There was a higher percentage of Ad36(+) children in the highest tertiles of TNF-α and IL-6 compared with their respective middle and lowest tertiles (both P < .03). There was also a trend toward a higher prevalence of Ad36(+) children in the highest tertile of VEGF compared with tertiles 1 and 2 (P = .05). Multinomial logistic regression, adjusting for age, race, sex, and fat-free soft tissue mass, revealed that compared with children with the lowest TNF-α, IL-6, and VEGF levels (tertile 1), the adjusted odds ratios for Ad36(+) were 2.2 [95% confidence interval (CI) 1.2-4.0], 2.4 (95% CI 1.4-4.0), and 1.8 (95% CI 1.0-3.3), respectively, for those in the highest TNF-α, IL-6, and VEGF levels (tertile 3). No association was observed between Ad36(+) and greater levels of fat mass or MCP-1 (all P > .05).

Conclusions: In children, our data suggest that Ad36(+) may be associated with biomarkers implicated in inflammation but not with greater levels of fat mass.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adenoviridae / immunology*
  • Adenovirus Infections, Human / epidemiology*
  • Adenovirus Infections, Human / immunology*
  • Adiposity / immunology*
  • Adolescent
  • Antibodies, Viral / blood
  • Biomarkers / blood
  • Chemokine CCL2 / blood
  • Child
  • Female
  • Humans
  • Inflammation / epidemiology*
  • Inflammation / immunology*
  • Interleukin-6 / blood
  • Male
  • Odds Ratio
  • Prevalence
  • Seroepidemiologic Studies
  • Tumor Necrosis Factor-alpha / blood
  • Vascular Endothelial Growth Factor A / blood

Substances

  • Antibodies, Viral
  • Biomarkers
  • CCL2 protein, human
  • Chemokine CCL2
  • IL6 protein, human
  • Interleukin-6
  • Tumor Necrosis Factor-alpha
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A